Российский журнал гастроэнтерологии, гепатологии, колопроктологии (Jun 2023)

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C

  • V. T. Ivashkin,
  • V. P. Chulanov,
  • N. A. Mamonova,
  • M. V. Maevskaya,
  • M. S. Zharkova,
  • I. N. Tikhonov,
  • P. O. Bogomolov,
  • E. V. Volchkova,
  • A. S. Dmitriev,
  • O. O. Znojko,
  • E. A. Klimova,
  • K. V. Kozlov,
  • I. E. Kravchenko,
  • E. Yu. Malinnikova,
  • R. V. Maslennikov,
  • M. I. Mikhailov,
  • K. E. Novak,
  • I. G. Nikitin,
  • V. E. Syutkin,
  • E. V. Esaulenko,
  • A. A. Sheptulin,
  • E. N. Shirokova,
  • N. D. Yushchuk

DOI
https://doi.org/10.22416/1382-4376-2023-33-1-84-124
Journal volume & issue
Vol. 33, no. 1
pp. 84 – 124

Abstract

Read online

Аim: diagnosis and treatment algorithms in the clinical recommendations intended for general practitioners, gastroenterologists, infectious disease specialists, hepatologists on the of chronic hepatitis C are presented.Summary. Chronic viral hepatitis C is a socially significant infection, the incidence of which in the Russian Federation remains significantly high. Over the past 10 years, great progress has been made in the treatment of hepatitis C — direct acting antiviral drugs have appeared. The spectrum of their effectiveness allows to achieve a sustained virological response in more than 90 % of cases, even in groups that were not previously considered even as candidates for therapy or were difficult to treat — patients receiving renal replacement therapy, after liver transplantation (or other organs), at the stage of decompensated liver cirrhosis, HIV co-infected, etc. Interferons are excluded from the recommendations due to their low effectiveness and a wide range of adverse events. The indications for the treatment have been expanded, namely, the fact of confirmation of viral replication. The terms of dispensary observation of patients without cirrhosis of the liver have been reduced (up to 12 weeks after the end of therapy). Also, these recommendations present approaches to active screening of hepatitis in risk groups, preventive and rehabilitation measures after the end of treatment.Conclusion. Great success has been achieved in the treatment of chronic hepatitis C. In most cases, eradication of viral HCV infection is a real task even in patients at the stage of cirrhosis of the liver, with impaired renal function, HIV co-infection, after solid organs transplantation.

Keywords